Imakethe yamasheya, ukuhwebelana kwamasheya namuhla
Ukucaphuna kwamasheya ezinkampanini ezingu-71229 ngesikhathi sangempela.
Imakethe yamasheya, ukuhwebelana kwamasheya namuhla

Izingcaphuno ze-Stock

Ukucaphuna kwamasheya ku-inthanethi

Umlando ucaphuna umlando

I-capital market capital

Izigaba ze-Stock

Inzuzo evela kumasheya enkampani

Imibiko yezezimali

Amanani wokulinganisa wezinkampani. Kukuphi ukutshalwa imali?

Novo Nordisk A/S umlando wesilinganiso samasheya

Inani lentengoNovo Nordisk A/S e Umqhele Danish ishadi kusukela ekuqaleni kokuhweba. Novo Nordisk A/S umlando wokubaluleka e Umqhele Danish kusukela 2000.
Engeza kumawijethi
Ingeziwe kumawijethi

Novo Nordisk A/S exchange stocks e Umqhele Danish umlando wamanani, ishadi kusukela ekuqaleni kokuhweba

Izindleko zamasheya Novo Nordisk A/S zishintshiwe zaba ngu--2.0416% ngesonto. Ngenyanga edlule, inani lentengo le-Novo Nordisk A/S lishintshele ku-+0.57%. Ukushintsha kwe-NOVO-B.CO intengo yesabelo sekota yokugcina kwaba ngu-+16.09%. Ngonyaka nangeminyaka emi-3, amanani okwabelana nge-Novo Nordisk A/S ashintshele ku-+39.4% no-+153.3%, ngokulandelana.

Bonisa:
Ukuze

Novo Nordisk A/S Umqhele Danish umlando wokubaluleka

 
Usuku Rate
2023 Kusuka 906.1 Ukuze 1 164.200 DKK
2022 Kusuka 608.9 Ukuze 940.9 DKK
2021 Kusuka 418 Ukuze 770.4 DKK
2020 Kusuka 352 Ukuze 465.95 DKK
2019 Kusuka 300.85 Ukuze 391.8 DKK
2018 Kusuka 267.3 Ukuze 323 DKK
2017 Kusuka 239.5 Ukuze 334.5 DKK
2016 Kusuka 238 Ukuze 379.1 DKK
2015 Kusuka 319.7 Ukuze 399.9 DKK
2014 Kusuka 231.8 Ukuze 295.5 DKK
2013 Kusuka 178.6 Ukuze 219 DKK
2012 Kusuka 154.5 Ukuze 202.2 DKK
2011 Kusuka 110.7 Ukuze 136.1 DKK
2010 Kusuka 77.2 Ukuze 125.8 DKK
2009 Kusuka 53.7 Ukuze 73.3 DKK
2008 Kusuka 54.2 Ukuze 67.4 DKK
2007 Kusuka 48.5 Ukuze 67 DKK
2006 Kusuka 36 Ukuze 49.3 DKK
2005 Kusuka 29.15 Ukuze 35.45 DKK
2004 Kusuka 27.8 Ukuze 32.8 DKK
2003 Kusuka 19.8 Ukuze 24.1 DKK
2002 Kusuka 17.85 Ukuze 33.95 DKK
2001 Kusuka 30.9 Ukuze 38.9 DKK
2000 Kusuka 33.7 Ukuze 33.7 DKK

Izindleko zamasheya Novo Nordisk A/S

Izezimali Novo Nordisk A/S